Reports Q2 revenue $1.035B, consensus $964M. “The Q2 was defined by performance and progress. We delivered double-digit total revenue growth and executed across all segments, despite ongoing supply chain issues. We also advanced our ambitious plan to reshape Bausch + Lomb and realize the company’s full potential,” said Brent Saunders, chairman and CEO, Bausch + Lomb. This note updates a prior version to use Bloomberg’s consensus figures.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BLCO:
- BLCO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bausch Health price target raised to $9 from $8 at RBC Capital
- Bausch + Lomb price target raised to $23 from $22 at Citi
- Bausch + Lomb buys J&J’s Blink eye and contact lens drops product line
- Bausch + Lomb price target raised to $23 from $19 at BofA
